Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Breast 2Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Melanoma 20Lymphoma, T-Cell, Cutaneous 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Non-Hodgkin 13Lymphoma, Mantle-Cell 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Large-Cell, Immunoblastic 12Lymphoma 12Burkitt Lymphoma 12Lymphoma, Large-Cell, Anaplastic 11Leukemia, Myeloid, Acute 11Hodgkin Disease 11Congenital Abnormalities 11Uveal Melanoma 9Sezary Syndrome 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Mycosis Fungoides 9Multiple Myeloma 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myeloid, Accelerated Phase 9Leukemia 9Immunoblastic Lymphadenopathy 9Waldenstrom Macroglobulinemia 8Recurrence 8Primary Myelofibrosis 8Myeloproliferative Disorders 8Myelodysplastic Syndromes 8

Interventions

pembrolizumab 36Cyclophosphamide 24Nivolumab 23Ipilimumab 22aldesleukin 19Interleukin-2 15fludarabine 14Specimen Handling 12Dacarbazine 11fludarabine phosphate 10Magnetic Resonance Spectroscopy 10Temozolomide 9Radiosurgery 9Biopsy 9cemiplimab 8Paclitaxel 8dabrafenib 5binimetinib 5Vemurafenib 5Radiotherapy 5Carboplatin 5trametinib 4sargramostim 4encorafenib 4avelumab 4Pemetrexed 4Leucovorin 4Fluorouracil 4Cisplatin 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Melphalan × Dermatologic × Clear all
NCT00324727 2021-06-21

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Delcath Systems Inc.

Phase 3 Completed
93 enrolled
Dermatologic

Uveal Melanoma, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡